Cargando…
SARS-CoV and IFN: Too Little, Too Late
Dysregulated type I interferon (IFN-I) expression can lead to severe pathology and disease. In this issue of Cell Host & Microbe, Channappanavar et al. (2016) use a SARS-coronavirus animal model to describe how rapid and robust virus replication with delayed IFN-I can lead to lung immunopatholog...
Autores principales: | Kindler, Eveline, Thiel, Volker |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104995/ https://www.ncbi.nlm.nih.gov/pubmed/26867172 http://dx.doi.org/10.1016/j.chom.2016.01.012 |
Ejemplares similares
-
COVID-19: too little, too late?
por: The Lancet
Publicado: (2020) -
Natalizumab for GVHD: too little or too late?
por: Quann, Kevin, et al.
Publicado: (2023) -
The Opioid Crisis in America: Too much, too little, too late
por: Koenig, Kristi L.
Publicado: (2018) -
Too little too late: Waiting for TB to come
por: Kawamura, L. Masae
Publicado: (2018) -
Correction of scientific literature: Too little, too late!
por: Besançon, Lonni, et al.
Publicado: (2022)